Baisong Liao

CEO

Benxin Therapeutics

Short Biography

Dr. Baisong Liao is co-funder and CEO of Benxin Therapeutics, with 20-year experience in development of novel drugs and molecular glue degraders. Dr. Liao has worked for Pfizer, Enzon，PPD and Kangpu as a senior leader. He made important contributions to advance 7 compounds into phase 2/3 trials and market. Dr. Liao had postdoctoral training at Rutgers university.

Presentation Topic: PPI-based molecular glue degrader design platform

• Challenges in molecular glue degrader design.
• Only a few molecular glue degraders are on market.
• Established PPI-based molecular glue degrader design platform